Aleš Holoubek

518 total citations
33 papers, 410 citations indexed

About

Aleš Holoubek is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Aleš Holoubek has authored 33 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 10 papers in Oncology and 6 papers in Hematology. Recurrent topics in Aleš Holoubek's work include Cancer-related Molecular Pathways (8 papers), Acute Myeloid Leukemia Research (6 papers) and Lipid Membrane Structure and Behavior (5 papers). Aleš Holoubek is often cited by papers focused on Cancer-related Molecular Pathways (8 papers), Acute Myeloid Leukemia Research (6 papers) and Lipid Membrane Structure and Behavior (5 papers). Aleš Holoubek collaborates with scholars based in Czechia, Switzerland and United States. Aleš Holoubek's co-authors include Barbora Brodská, Kateřina Kuželová, Karel Sigler, Jaroslav Večeř, Petr Heřman, Dana Grebeňová, Dana Gášková, Michael A. Model, Miroslava Opekarová and Jana Humpolíčková and has published in prestigious journals such as Nature Communications, PLoS ONE and Analytical Biochemistry.

In The Last Decade

Aleš Holoubek

31 papers receiving 408 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aleš Holoubek Czechia 13 279 92 67 33 30 33 410
Catherine Bardelle United Kingdom 12 237 0.8× 66 0.7× 73 1.1× 16 0.5× 21 0.7× 20 395
Tao Xie United States 7 275 1.0× 62 0.7× 70 1.0× 7 0.2× 28 0.9× 18 452
Sara Helander Sweden 11 361 1.3× 75 0.8× 12 0.2× 26 0.8× 20 0.7× 11 473
Anna Koren Austria 10 473 1.7× 178 1.9× 34 0.5× 12 0.4× 12 0.4× 17 583
Marie Wiltshire United Kingdom 14 313 1.1× 94 1.0× 23 0.3× 102 3.1× 68 2.3× 28 582
Erika Orbán Hungary 18 496 1.8× 185 2.0× 22 0.3× 14 0.4× 51 1.7× 34 753
Julie Cramard Netherlands 6 437 1.6× 36 0.4× 28 0.4× 28 0.8× 18 0.6× 6 541
Catherine Ibarra United States 12 227 0.8× 49 0.5× 22 0.3× 16 0.5× 10 0.3× 14 320
G. Valet Germany 11 223 0.8× 107 1.2× 15 0.2× 30 0.9× 42 1.4× 21 403

Countries citing papers authored by Aleš Holoubek

Since Specialization
Citations

This map shows the geographic impact of Aleš Holoubek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aleš Holoubek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aleš Holoubek more than expected).

Fields of papers citing papers by Aleš Holoubek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aleš Holoubek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aleš Holoubek. The network helps show where Aleš Holoubek may publish in the future.

Co-authorship network of co-authors of Aleš Holoubek

This figure shows the co-authorship network connecting the top 25 collaborators of Aleš Holoubek. A scholar is included among the top collaborators of Aleš Holoubek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aleš Holoubek. Aleš Holoubek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Holoubek, Aleš, et al.. (2025). Correlation of p53 oligomeric status and its subcellular localization in the presence of the AML-associated NPM mutant. PLoS ONE. 20(5). e0322096–e0322096. 1 indexed citations
2.
Malý, Pavel, et al.. (2024). Interferometric excitation fluorescence lifetime imaging microscopy. Nature Communications. 15(1). 8019–8019. 4 indexed citations
3.
Holoubek, Aleš, et al.. (2023). Two-photon lifetime-based photoconversion of EGFP for 3D-photostimulation in FLIM. Methods and Applications in Fluorescence. 11(3). 34002–34002.
4.
Holoubek, Aleš, et al.. (2023). Nucleolar phosphoprotein modifications as a marker of apoptosis induced by RITA treatment. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1870(7). 119501–119501. 2 indexed citations
5.
Holoubek, Aleš, et al.. (2023). Cytoplasmic localization of Mdm2 in cells expressing mutated NPM is mediated by p53. FEBS Journal. 290(17). 4281–4299. 3 indexed citations
6.
Marková, Jana, et al.. (2023). A novel germline hyperactivating JAK2 mutation L604F. Annals of Hematology. 102(10). 2725–2734.
7.
Krejčík, Zdeněk, Aleš Holoubek, Jǐŕı Kléma, et al.. (2023). Expression of circular RNAs in myelodysplastic neoplasms and their association with mutations in the splicing factor gene SF3B1. Molecular Oncology. 17(12). 2565–2583. 6 indexed citations
8.
Heřman, Petr, et al.. (2021). NSC348884 cytotoxicity is not mediated by inhibition of nucleophosmin oligomerization. Scientific Reports. 11(1). 10 indexed citations
9.
10.
Kuželová, Kateřina, et al.. (2021). Group I p21-activated kinases in leukemia cell adhesion to fibronectin. Cell Adhesion & Migration. 15(1). 18–36. 6 indexed citations
11.
Antonarakis, Stylianos E., Aleš Holoubek, J Meylan, et al.. (2021). Dominant monoallelic variant in the PAK2 gene causes Knobloch syndrome type 2. Human Molecular Genetics. 31(1). 1–9. 8 indexed citations
12.
Holoubek, Aleš, et al.. (2021). AML-Related NPM Mutations Drive p53 Delocalization into the Cytoplasm with Possible Impact on p53-Dependent Stress Response. Cancers. 13(13). 3266–3266. 1 indexed citations
13.
Grebeňová, Dana, et al.. (2019). PAK1, PAK1Δ15, and PAK2: similarities, differences and mutual interactions. Scientific Reports. 9(1). 17171–17171. 20 indexed citations
14.
Holoubek, Aleš, et al.. (2018). AML-associated mutation of nucleophosmin compromises its interaction with nucleolin. The International Journal of Biochemistry & Cell Biology. 103. 65–73. 13 indexed citations
15.
Brodská, Barbora, et al.. (2017). Localization of AML-related nucleophosmin mutant depends on its subtype and is highly affected by its interaction with wild-type NPM. PLoS ONE. 12(4). e0175175–e0175175. 19 indexed citations
16.
Brodská, Barbora, et al.. (2015). Low‐Dose Actinomycin‐D Induces Redistribution of Wild‐Type and Mutated Nucleophosmin Followed by Cell Death in Leukemic Cells. Journal of Cellular Biochemistry. 117(6). 1319–1329. 23 indexed citations
17.
Kuželová, Kateřina, et al.. (2014). Group I PAK Inhibitor IPA-3 Induces Cell Death and Affects Cell Adhesivity to Fibronectin in Human Hematopoietic Cells. PLoS ONE. 9(3). e92560–e92560. 19 indexed citations
18.
Kuželová, Kateřina, et al.. (2013). Live fluorescence and transmission-through-dye microscopic study of actinomycin D-induced apoptosis and apoptotic volume decrease. APOPTOSIS. 18(4). 521–532. 29 indexed citations
19.
20.
Večeř, Jaroslav, Petr Heřman, & Aleš Holoubek. (1997). Diffusion membrane potential in liposomes: setting by ion gradients, absolute calibration and monitoring of fast changes by spectral shifts of diS-C3(3) fluorescence maximum. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1325(2). 155–164. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Catherine Bardelle Breakdown of academic impact, for papers by Tao Xie Breakdown of academic impact, for papers by Sara Helander Breakdown of academic impact, for papers by Anna Koren Breakdown of academic impact, for papers by Marie Wiltshire Breakdown of academic impact, for papers by Erika Orbán Breakdown of academic impact, for papers by Julie Cramard Breakdown of academic impact, for papers by Catherine Ibarra Breakdown of academic impact, for papers by G. Valet
Rankless by CCL
2026